Biorelix
New Haven, US
Biotech
Founders & leadership
PC
Philippe ChambonNamed on SEC filing
BR
Brian R. Dixon, Ph.DNamed on SEC filing
AD
A. Donny StrosbergNamed on SEC filing
RL
Ronald LennoxNamed on SEC filing
WW
William WieslerNamed on SEC filing
CM
Campbell MurrayNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$2.6M disclosed across 1 round · 2012
▶$2.6MraisedMar 2012 · 8 investors · PharmaceuticalsRule 506(b)
▶$2.6MraisedMar 2012 · 8 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Philippe ChambonDirector
- Brian R. Dixon, Ph.DExecutive Officer, Director
- A. Donny StrosbergDirector
- Ronald LennoxExecutive Officer, Director
- William WieslerDirector
- Campbell MurrayDirector
- Offering amount
- $2.6M
- Amount sold
- $2.6M
- First sale
- Mar 2012
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.